Ali Taheri

Dr Ali Taheri

Higher Degree by Research Candidate

School of Pharmacy and Biomedical Sciences

College of Health


Year Citation
2026 Taheri, A., Bremmell, K. E., Hickey, S. M., Joyce, P., & Prestidge, C. A. (2026). Oral delivery of topoisomerase I inhibitors: From biopharmaceutical barriers to clinical translation.. Journal of controlled release : official journal of the Controlled Release Society, 115166.
DOI
2025 Subramaniam, S., Donnellan, L., Wignall, A., Woodcock, J., Coolen, C., Pitson, S., . . . Joyce, P. (2025). Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drug. Journal of Controlled Release, 388(Pt 1), 114299.
DOI Scopus5 WoS5 Europe PMC2
2025 Taheri, A., Almasri, R., Wignall, A., Feltrin, F., Bremmell, K. E., Joyce, P., & Prestidge, C. A. (2025). Enteric coating enhances the Biopharmaceutical performance of a silica-lipid formulation of Abiraterone Acetate. Pharmaceutics, 17(10, article no. 1289), 1-12.
DOI
2024 Taheri, A., Almasri, R., Wignall, A., Schultz, H. B., Elz, A. S., Ariaee, A., . . . Prestidge, C. A. (2024). Enhancing the pharmacokinetics of abiraterone acetate through lipid-based formulations: addressing solubility and food effect challenges. Drug Delivery and Translational Research, online(11), 3770-3782.
DOI Scopus5 WoS6 Europe PMC2
2023 Taheri, A., Bremmell, K. E., Joyce, P., & Prestidge, C. A. (2023). Battle of the milky way: lymphatic targeted drug delivery for pathogen eradication. Journal of Controlled Release, 363, 507-524.
DOI Scopus15 WoS10 Europe PMC8
2023 Tabarsi, P., Anjidani, N., Shahpari, R., Mardani, M., Sabzvari, A., Yazdani, B., . . . Barati, S. (2023). Evaluating the efficacy and safety of SpikoGen?, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial. CLINICAL MICROBIOLOGY AND INFECTION, 29(2), 215-220.
DOI WoS38 Europe PMC37
2022 Tabarsi, P., Anjidani, N., Shahpari, R., Mardani, M., Sabzvari, A., Yazdani, B., . . . Barati, S. (2022). Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations. CLINICAL MICROBIOLOGY AND INFECTION, 28(9), 1263-1271.
DOI WoS40 Europe PMC42
2022 Rezaei, S., Taheri, A., Taheri, S., Kasirzadeh, S., Fatemi, B., & Sorato, M. M. (2022). Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 15(6), 767-777.
DOI WoS3 Europe PMC3
2021 Kasirzadeh, S., Ghahremani, M. H., Setayesh, N., Jeivad, F., Shadboorestan, A., Taheri, A., . . . Sabzevari, O. (2021). β-Sitosterol Alters the Inflammatory Response in CLP Rat Model of Sepsis by Modulation of NFκB Signaling. BIOMED RESEARCH INTERNATIONAL, 2021(1), 11 pages.
DOI WoS31 Europe PMC27
2021 Rezaei, S., Fatemi, B., Karimi Majd, Z., Minaei, H., Peikanpour, M., Anjidani, N., . . . Mosaed, R. (2021). Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 17(5), 499-511.
DOI WoS23 Europe PMC22
2019 Taheri, A., Emami, M., Asadipour, E., Kasirzadeh, S., Rouini, M. -R., Najafi, A., . . . Mojtahedzadeh, M. (2019). A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury. JOURNAL OF NEUROLOGY, 266(8), 1988-1997.
DOI WoS31 Europe PMC26
2018 Taheri, A., Lavasani, H., Kasirzadeh, S., Sheikholeslami, B., Ardakani, Y. H., & Rouini, M. -R. (2018). Changes in CYP2D enzyme activity following induction of type 2 diabetes, and administration of cinnamon and metformin: an experimental animal study. XENOBIOTICA, 48(10), 984-989.
DOI WoS7 Europe PMC5

Courses I teach

  • PUBH 3008 UO Epidemiological Principles and Methods (2026)
  • MATH 1065 Quantitative Methods in Health (2025)
  • PHAR 2014 Dosage Form Design 1 (2025)
  • PHAR 2014 Dosage Form Design 1 (2024)
  • PHAR 2016 Dosage Form Design 2 (2024)

Connect With Me

External Profiles

Other Links